Influenza
54 drugs7,972 FAERS reportsMedDRA PT
GET
/api/v1/reaction/influenzaReference statistics only. FAERS reports are voluntarily submitted and are not incidence rates, safety signals, or causal evidence. The drugs below are ranked by how often this reaction appears on FAERS reports for each drug — high share does not mean the drug caused the reaction, and absence from this list does not mean the reaction never occurred. This is not a symptom checker.
DefinitionNLM MeSH D007251
An acute viral infection in humans involving the respiratory tract. It is marked by inflammation of the NASAL MUCOSA; the PHARYNX; and conjunctiva, and by headache and severe, often generalized, myalgia.
Source: U.S. National Library of Medicine — MeSH (Influenza, Human)
Drugs reporting Influenza (54)
Share = reports listing this reaction ÷ total matched reports for the drug. — means the upstream totals query failed at ingest and the denominator is unknown.
- 1Policresulen1100%
- 2Coal Tar20627%
- 3Chlorcyclizine519%
- 4Mavorixafor117%
- 5Formaldehyde1015%
- 6Phenoxybenzamine312%
- 7Clesrovimab19.1%
- 8Nedosiran18.3%
- 9Xenon17.7%
- 10Aprocitentan17.1%
- 11Nipocalimab106.4%
- 12Idursulfase2305.9%
- 13Acitretin2755.7%
- 14Sinusitisinum35.4%
- 15Curcumin65.1%
- 16Zinc Picolinate65.1%
- 17Apple Cider Vinegar65.0%
- 18Cider Vinegar65.0%
- 19Influenza B Virus174.9%
- 20Apple Cider64.9%
- 21Oseltamivir1,1724.9%
- 22Trofinetide2844.7%
- 23Chlophedianol34.5%
- 24Benzgalantamine24.3%
- 25Terbutaline744.1%
- 26Peramivir63.9%
- 27Vamorolone523.6%
- 28Tavaborole23.6%
- 29Deflazacort2093.3%
- 30Ocrelizumab2,0063.3%
- 31Palivizumab5013.3%
- 32Laronidase1283.2%
- 33Pyrrole82.9%
- 34Baloxavir592.6%
- 35Baloxavir Marboxil592.6%
- 36Donidalorsen42.5%
- 37Betaine382.5%
- 38Elexacaftor2932.4%
- 39Galsulfase912.4%
- 40Glycerol Phenylbutyrate312.4%
- 41Carglumic Acid172.3%
- 42Elosulfase Alfa1222.3%
- 43Dornase Alfa4472.3%
- 44Casimersen192.3%
- 45Eteplirsen482.2%
- 46Lumacaftor1842.2%
- 47Tezacaftor3852.2%
- 48Ivacaftor7222.2%
- 49Elapegademase62.1%
- 50Phenylbutyrate332.0%
- 51Nusinersen1482.0%
- 52Viltolarsen31.9%
- 53Golodirsen81.9%
- 54Leniolisib131.8%
Related reactions
Other reactions most often co-reported on the same drug set. Ranked by Jaccard similarity over drug-id sets — pure data-derived co-occurrence, not a clinical relationship.
- Nasopharyngitis23 shared · 0.17
- Illness15 shared · 0.15
- Sinusitis12 shared · 0.14
- Covid-1921 shared · 0.10
- Poor Venous Access5 shared · 0.09
- Infusion Site Erythema5 shared · 0.09
- Arthritis6 shared · 0.08
- Cystic Fibrosis5 shared · 0.08
- Infective Pulmonary Exacerbation Of Cystic Fibrosis5 shared · 0.08
- Cough35 shared · 0.08
Literature
Recent PubMed references pinned to Influenza, Human as a MeSH major topic. About the reaction term itself — not about any specific drug.
- Comparison of safety and immunogenicity between high-dose and low-dose quadrivalent influenza vaccines in children aged 6-35 months in China: A randomized, double-blind clinical study.Human vaccines & immunotherapeutics · 2026 · Guo X, Li J, Dong X, et al.PMID 42203214DOI 10.1080/21645515.2026.2665017
- Evaluation of influenza vaccine effectiveness among older adults in Jiaxing, China, 2022-2025: A test negative design-based study.Human vaccines & immunotherapeutics · 2026 · Liu Y, Fu X, Wang Y, et al.PMID 42202217DOI 10.1080/21645515.2026.2665969
- Gut Microbiota and Probiotics in Influenza: A Narrative Review of Mechanisms and Emerging Evidence.Viruses · 2026 · Guan F, Zhang J, Tian Y, et al.PMID 42198756DOI 10.3390/v18050553
- Emergence and Evolution of Triple Reassortant Highly Pathogenic Avian Influenza A(H5N1) Virus, Argentina, 2025.Viruses · 2026 · Benedetti E, Artuso MC, Byrne A, et al.PMID 42198727DOI 10.3390/v18050525
- Influenza A(H3N2) Subclade K: Epidemiology, Molecular Evolution and Vaccine Effectiveness in Europe.Pathogens (Basel, Switzerland) · 2026 · Scarvaglieri I, De Francesco MA, Alberti M, et al.PMID 42198601DOI 10.3390/pathogens15050474
- Algorithm-Optimized H5 Influenza mRNA Vaccine Induces Broad Immune Responses.International journal of molecular sciences · 2026 · Wang L, Peng Z, He C, et al.PMID 42196525DOI 10.3390/ijms27104547
Note. FAERS reports are voluntarily submitted and are NOT incidence rates, signals, or causal evidence. Counts reflect reporting volume, not how often a reaction occurs. Reference statistics only.